Skip to main content
SpringerLink
Log in

The biology of the human ligand for CD40

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403–1410, 1989

    Google Scholar 

  2. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023, 1990

    Google Scholar 

  3. Mallett S, Barclay AN: A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today 12:220–223, 1991

    Google Scholar 

  4. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421–427, 1992

    Google Scholar 

  5. Clark EA: CD40: A cytokine receptor in search of a ligand. Tissue Antigens 36:33–36, 1990

    Google Scholar 

  6. Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F: Long term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70–72, 1991

    Google Scholar 

  7. Jabara HH, Fu SM, Geha RS, Vercelli D: CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin-6 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172:1861–1864, 1990

    Google Scholar 

  8. Rousset F, Garcia E, Banchereau J: Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 173:705–710, 1991

    Google Scholar 

  9. Zhang K, Clark EA, Saxon A: CD40 stimulation provides and IFN-γ-independent and IL-4-dependent differentiation directly to human B cells for IgE production. J Immunol 146:1836–1842, 1991

    Google Scholar 

  10. Gascan H, Gauchat J-F, Aversa G, van Vlasselaer P, de Vries JE: Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signalling pathways. J Immunol 147:8–13, 1991

    Google Scholar 

  11. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890–1893, 1992

    Google Scholar 

  12. Shapira SK, Vercelli D, Jabara HH, Fu SM, Geha RS: Molecular analysis of the induction of immunoglobulin E synthesis in human B cell by interleukin 4 and engagement of CD40 antigen. J Exp Med 175:289–292, 1992

    Google Scholar 

  13. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennon ICM: Mechanism of antigen-driven selection in germinal centres. Nature (London) 342:929–931, 1989

    Google Scholar 

  14. Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, Mac Lennan IC: Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21:1107–1114, 1991

    Google Scholar 

  15. Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, Mac Lennan IC: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905–1910, 1991

    Google Scholar 

  16. Galy AH, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149:775–782, 1992

    Google Scholar 

  17. Gordon J, Millsum MJ, Guy GR, Ledbetter JA: Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. J Immunol 140:1425, 1988

    Google Scholar 

  18. Barrett TB, Shu G, Clark EA: CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 146:1722, 1991

    Google Scholar 

  19. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and Immunoglobulin E secretion. J Exp Med 176:1543–1550, 1992

    Google Scholar 

  20. Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22:3191–3194, 1992

    Google Scholar 

  21. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny ND, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J 11:4313–4321, 1992

    Google Scholar 

  22. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK: Molecular and biological characterization of a murine ligand for CD40. Nature (London) 357:80–82, 1992

    Google Scholar 

  23. Farrah T, Smith CA: Emerging cytokine family. Nature (London) 358:26, 1992

    Google Scholar 

  24. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993, 1993

    Google Scholar 

  25. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291–300, 1993

    Google Scholar 

  26. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper IgM. Nature (London) 361:539–541, 1993

    Google Scholar 

  27. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G: CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (London) 361:541–543, 1993

    Google Scholar 

  28. Geha RS, Hyslop N, Alami S, Farah F, Schneeberger EE, Rosen FS: Hyper immunoglobulin M immunodeficiency. (Dysgammaglobulinemia). Presence of immunoglobulin M-secreting plasmacytoid cells in peripheral blood and failure of immunoglobulin M-immunoglobulin G switch in B-cell differentiation. J Clin Invest 64:385–391, 1979

    Google Scholar 

  29. Noelle RJ, McCann J, Marshall L, Bartlett WC: Cognate interactions between helper B cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells. J Immunol 143:1807, 1989

    Google Scholar 

  30. Noelle RJ, Snow EC: T helper cell-dependent B cell activation. FASEB J 5:2770–2706, 1991

    Google Scholar 

  31. Noelle RJ, Daum J, Bartlett WC, McCann J, Shepherd DM: Cognate interactions between helper T cells and B cells. V. Reconstitution of helper T cell function using purified plasma membranes from activated Th1 and Th2 helper T cells and lymphokines. J Immunol 146:1118–1124, 1990

    Google Scholar 

  32. Brian AA: Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc Natl Acad Sci USA 85:564–568, 1988

    Google Scholar 

  33. Sekita K, Straub C, Hoessli D, Zubler RH: B cell-stimulating activity of lymphoid cell membrane fractions. Eur J Immunol 18:1405–1410, 1988

    Google Scholar 

  34. Hodgkin PD, Yamashita LC, Coffman RL, Kehry MR: Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol 145:2025–2034, 1990

    Google Scholar 

  35. Fanslow WC, Anderson D, Grabstein KH, Clark EA, Cosman D, Armitage RJ: Soluble forms of CD40 inhibit biological responses of human B cells. J Immunol 149:655–660, 1992

    Google Scholar 

  36. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE: A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821–2832, 1991

    Google Scholar 

  37. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC: Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150:3671–3680, 1993

    Google Scholar 

  38. Andersson J, Schreier MH, Melchers F: T-cell-dependent B-cell stimulation isH-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci USA 77:1612–1616, 1980

    Google Scholar 

  39. Peitsch MC, Jongeneel CV: A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol 5:233–238, 1993

    Google Scholar 

  40. Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR: CD40 ligand is a T-cell growth factor. Eur J Immunol (in press), 1993

  41. Copeland NG, Jenkins NA: Development and applications of a molecular genetic linkage map of the mouse genome. Trends Genet 7:113–118, 1991

    Google Scholar 

  42. Mensink EJ, Thompson A, Sandkuyl LA, Kraakman ME, Schot JD, Espanol T, Schuurman RK: X-linked immunodeficiency with hyperimmunoglobulinemia M appears to be linked to the DXS42 restriction fragment length polymorphism locus. Hum Genet 76:96–99, 1987

    Google Scholar 

  43. Padayachee M, Feighery C, Finn A, McKeown C, Levinsky RJ, Kinnon C, Malcolm S: Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 14:551–553, 1992

    Google Scholar 

  44. Rosen FS, Kevy SV, Merler E, Janeway CA, Gitlin D: Recurrent bacterial infections and dysgammaglobulinemia: Deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Pediatrics 28:182–195, 1961

    Google Scholar 

  45. Notarangelo LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3:101–121, 1992

    Google Scholar 

  46. Conley ME: Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol 10:215–238, 1992

    Google Scholar 

  47. Mayer L, Kwan SP, Thompson C, Ko HS, Chiorazzi N, Waldmann T, Rosen F: Evidence for a defect in “switch” T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med 314:409–413, 1986

    Google Scholar 

  48. Levitt D, Haber P, Rich K, Cooper MD: Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching. J Clin Invest 72:1650–1657, 1983

    Google Scholar 

  49. Hendriks RW, Kraakman ME, Craig IW, Espanol T, Schuurman RK: Evidence that in X-linked immunodeficiency with hyperimmunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact. Eur J Immunol 20:2603–2608, 1990

    Google Scholar 

  50. Fanslow WC, Clifford KY, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell F: Recombinant CD40-ligand exerts potent biological effects on T cells. J Immunol (in press) 1993

  51. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669, 1993

    Google Scholar 

  52. Allen RC, Spriggs MK, Belmont JW: Dinucleotide repeat polymorphism in the human CD40 ligand gene. Hum Mol Genet 2:828, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunex Research and Development Corporation, 51 University Street, 98101, Seattle, Washington

    Melanie K. Spriggs, William C. Fanslow & Richard J. Armitage

  2. Howard Hughes Medical Institute, Institute for Molecular Genetics, Baylor College of Medicine, 77030, Houston, Texas

    John Belmont

Authors
  1. Melanie K. Spriggs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William C. Fanslow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard J. Armitage
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Belmont
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spriggs, M.K., Fanslow, W.C., Armitage, R.J. et al. The biology of the human ligand for CD40. J Clin Immunol 13, 373–380 (1993). https://doi.org/10.1007/BF00920012

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00920012

Key words

Search

Navigation